1998
DOI: 10.1016/s0002-9149(97)00866-7
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Outcome at Six Months of Coronary Stenting Followed by Ticlopidine Monotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
1

Year Published

1999
1999
2002
2002

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 28 publications
0
1
1
Order By: Relevance
“…The surveyed institutes are considered to represent the major hospitals in Japan actively treating AMI patients with PCI, because the average volume of emergency PCI for AMI of 187 cases per 3 years (62.4 cases / year per institute) in the present study is much higher than the average annual volume of 26.8 cases per institute in the Japanese Coronary Intervention Study 4 and the 12.3 cases per institute in the survey by Watanabe et al 3 The incidence of subacute stent thrombosis of 3.0% in the present study was slightly higher than the previously reported rate of 0.5-2.5% [27][28][29][30][31][32] and can be explained by the fact that all stenting procedures were emergencies for AMI and not all patients were taking ticlopidine after the procedure.…”
Section: Present Studycontrasting
confidence: 64%
See 1 more Smart Citation
“…The surveyed institutes are considered to represent the major hospitals in Japan actively treating AMI patients with PCI, because the average volume of emergency PCI for AMI of 187 cases per 3 years (62.4 cases / year per institute) in the present study is much higher than the average annual volume of 26.8 cases per institute in the Japanese Coronary Intervention Study 4 and the 12.3 cases per institute in the survey by Watanabe et al 3 The incidence of subacute stent thrombosis of 3.0% in the present study was slightly higher than the previously reported rate of 0.5-2.5% [27][28][29][30][31][32] and can be explained by the fact that all stenting procedures were emergencies for AMI and not all patients were taking ticlopidine after the procedure.…”
Section: Present Studycontrasting
confidence: 64%
“…[23][24][25][26] However, more recent methods using intravascular ultrasound, high-pressure post-dilatation, and an anti-platelet regimen with aspirin and ticlopidine have lead to a dramatic reduction in the rate of thrombosis to 0.5-2.5% [27][28][29][30][31][32] and most events occur within 5 days of the procedure. 31,32 The predisposing factors of stent thrombosis that have been identified in previous studies 29,31 include low ejection fraction, absence of hypertension, a combination of different stents, longer stent length, residual dissections, slow flow, and final lumen diameter, but no study has identified ETT or training as a predisposing or triggering factor.…”
Section: Predisposing Factors To Stent Thrombosismentioning
confidence: 99%